Biopharmaceutical giant Bristol-Myers Squibb reached a deal to acquire Celgene, a maker of treatments for cancer and inflammatory diseases.
from USATODAY - Money Top Stories http://bit.ly/2F3s4zr
Biopharmaceutical giant Bristol-Myers Squibb reached a deal to acquire Celgene, a maker of treatments for cancer and inflammatory diseases.
0 Comments